![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 ACCORD HEALTHCARE LIMITED (2)
02 BAXTER SpA (2)
03 EBEWE Pharma Ges.m.b.H Nfg. KG (2)
04 EBEWE Pharma Ges.m.b.H.Nfg.KG (1)
05 MEDA PHARMA SpA (1)
06 MEDA Pharma GmbH (2)
07 Meda - Asker (1)
08 Meda AB (1)
09 Mylan Hospital AS (1)
10 SANDOZ SpA (2)
11 Sandoz Pharmaceuticals AG (2)
12 Blank (3)
01 Mitoxantrone (17)
02 mitoxantronhydroklorid (3)
01 CONCENTRATE FOR SOLUTION FOR INFUSION (1)
02 Concentrate to the infusion fluid (3)
03 Concentrated Infusion Solution (1)
04 Concentrated Solution Perfusion (1)
05 Infusion (2)
06 Injection (2)
07 KONCENTRAT TILL INFUSIONSVÄTSKA, LÖSNING (2)
08 Mitoxantrone 10Mg 5Ml 1 Units Parenteral Use (3)
09 Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use (4)
10 Solution For Injection Iv (1)
01 Italy (7)
02 Norway (3)
03 Spain (3)
04 Sweden (3)
05 Switzerland (4)
01 Mitoxantron Ebewe (3)
02 Mitoxantrone (4)
03 Mitoxantrone Accord 2Mg/Ml 1 Vial 10Ml Drip Soluc Concentr Efg (1)
04 Mitoxantrone Mylan (1)
05 Mitoxantrone Sandoz 2Mg/Ml 10Ml Concentrated Solution Infusion (1)
06 Novantrone (2)
07 Novantrone 20Mg 1 Vial 10Ml Solution For Injection (1)
08 Onkotrone (2)
09 novantrone (1)
10 Blank (4)